7/26/2009Joinn Laboratories passes GLP inspection of USFDA

7/17/2009Pfizer and Wyeth gets EU approval for merger

7/17/2009New CHI report: Outsourcing Preclinical Studies to China: Benefits and...

7/14/2009Visiongain: Clinical trials market worth $50bn in 2008

7/10/2009Pfizer loses final battle for Chinese trademark of Viagra

7/3/2009CROs in Zhangjiang to receive express customs clearance

6/16/2009Pfizer may conclude more deals in emerging markets in the next few mon...

6/8/2009HUYA Bioscience Announces Strategic Collaboration With the Shenyang Ph...

6/8/2009MDS boosts discovery pharmacology capabilities in Asia

6/2/2009Dishman's Shanghai facility to be operational soon

6/2/2009New CRO platform established in Nanjing

5/22/2009XenoBiotic Labs to begin its Chinese operation in summer

5/21/2009Asymchem opens API and drug product facility in Tianjin

5/21/2009Pfizer reaches licensing deals with two leading Indian generic firms ...

5/19/2009New clinical CRO formed in Tianjin

5/13/2009Biopharma R&D supply chain alliance formed

5/11/2009Pfizer boosts stem cell R&D with US$100 million investment

4/16/2009GSK and Pfizer form joint venture for HIV drugs

4/7/2009Pfizer announces restructure plan after Wyeth acquisition

3/31/2009ReSearch Pharma Acquires Paramax

3/31/2009Pfizer to outsource phencyclidine from Shanxi company

3/30/2009Global pharma industry consolidation may boost outsourcing to India an...

3/21/2009Pfizer seeks to enter lower tier Chinese markets through partnership w...

3/9/2009Pfizer and Sanofi Aventis eye Wockhardt's biotech business

3/6/2009Pfizer China and Peking University forms joint quantitative pharmacolo...

3/4/2009MNCs report another year of sharp revenue growth in China

3/3/2009Pfizer acquires generic drug rights from Aurobindo

3/2/2009Pfizer opens new facility in Dalian

2/24/2009Shanghai Drug Clinical Research Center established

2/20/2009Duke University researchers questions clinical trials overseas

Page:23/25 Total number of articles:744: [First][<<] [21] [22] [23] [24] [25] [>>] [End]